Skip to content

Jonathan McNeill, President and COO at Crescent Biopharma, sold CBIO on Sep 18, 2026

Data as of Oct 16

▼ SELL$64.2K3,839 shares at $16.71Jonathan McNeill President and COOCBIO Crescent Biopharma, Inc.
Watch CBIO
Traded
Sep 18, 2026
Disclosed
Sep 18, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jonathan McNeill, President and COO at Crescent Biopharma, sold CBIO on Sep 18, 2026TRADEDDISCLOSED
CBIOSimilar stocks (XLV — its sector index fund), rebased to CBIO's price on the disclosure day
CBIO since disclosure
−29.9%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Sep 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJonathan McNeill President and COOCBIO Crescent Biopharma, Inc.$13.1Kdisclosed Sep 18 · filed 2 days after the trade

See every trade on CBIO →